September 12, 2018 Healio Apellis begins phase 3 clinical program for geographic atrophy treatment September 12, 2018 Seeking Alpha Dosing underway in Apellis Pharma's late-stage program of APL-2 in geographic a… August 31, 2018 Retinal Physician SUBSPECIALTY NEWS: Sustained-release drug, 12-week dosing, and more August 23, 2018 Boston Business Journal Kentucky biotech Apellis plans major expansion in Mass July 28, 2018 Healio, Ocular Surgery News Apellis begins phase 3 clinical program for geographic atrophy program July 24, 2018 Endpoints News FDA hands Apellis Pharmaceuticals fast track designation for its advanced dry A… July 24, 2018 Healio, Ocular Surgery News Fast track designation granted for Apellis’ geographic atrophy treatment July 22, 2018 Modern Retina What APL-2 means for geographic atrophy July 22, 2018 Medscape New Geographic Atrophy Treatment Shows Promise June 28, 2018 Chief Executive Q&A: Apellis Pharmaceuticals CEO Dr. Cedric Francois
September 12, 2018 Seeking Alpha Dosing underway in Apellis Pharma's late-stage program of APL-2 in geographic a…
August 31, 2018 Retinal Physician SUBSPECIALTY NEWS: Sustained-release drug, 12-week dosing, and more
July 28, 2018 Healio, Ocular Surgery News Apellis begins phase 3 clinical program for geographic atrophy program
July 24, 2018 Endpoints News FDA hands Apellis Pharmaceuticals fast track designation for its advanced dry A…
July 24, 2018 Healio, Ocular Surgery News Fast track designation granted for Apellis’ geographic atrophy treatment